Autopsy report · NCT02791555
Effect of Pradaxa vs Warfarin on Bone Mass and Bone Turnover Markers
Cause of deathSlow enrollment
“Study was terminated early due to low enrollment numbers.”
Life of this trial
- Ran for about 9 months before it stopped.
- 2 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- UConn Health
- Sponsor type
- University, hospital or other
- Conditions
- Atrial Fibrillation
- Participants
- 2
- Sites
- 1
- Countries
- United States
Trials that died the same way
- MIRACLE EF Clinical Study
“The study was terminated early due to low enrollment.” - A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma
“Due to low enrollment, this study was terminated early.” - BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations
“Study was terminated due to low enrollment.” - A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients
“This study was terminated early due to poor enrollment.” - A Study to Evaluate Lumasiran in Adults With Recurrent Calcium Oxalate Kidney Stone Disease and Elevated Urinary Oxalate Levels
“Study terminated early due to low enrollment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.